Scpharmaceuticals Stock Investor Sentiment
| SCPH Stock | USD 4.12 0.38 8.44% |
Under 68% of Scpharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Scpharmaceuticals stock suggests that many investors are alarmed at this time. Scpharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Scpharmaceuticals. The current market sentiment, together with Scpharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Scpharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Scpharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Scpharmaceuticals daily returns and investor perception about the current price of Scpharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Scpharmaceuticals |
Scpharmaceuticals Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Scpharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Scpharmaceuticals that are available to investors today. That information is available publicly through Scpharmaceuticals media outlets and privately through word of mouth or via Scpharmaceuticals internal channels. However, regardless of the origin, that massive amount of Scpharmaceuticals data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Scpharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Scpharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Scpharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Scpharmaceuticals alpha.
Scpharmaceuticals Performance against NYSE Composite
Price Growth (%) |
| Timeline |
1 | scPharmaceuticals files for 200M mixed shelf offering | 03/13/2024 |
2 | HC Wainwright Reaffirms Buy Rating for scPharmaceuticals - MarketBeat | 03/18/2024 |
3 | Acquisition by John Tucker of 56025 shares of Scpharmaceuticals at 7.06 subject to Rule 16b-3 | 03/28/2024 |
4 | Acquisition by Veitinger Klaus R Dr of 16300 shares of Scpharmaceuticals at 4.53 subject to Rule 16b-3 | 04/05/2024 |
5 | Acquisition by Jack Khattar of 17300 shares of Scpharmaceuticals at 11.71 subject to Rule 16b-3 | 04/16/2024 |
6 | Disposition of 220096 shares by 5am Partners Iv, Llc of Scpharmaceuticals at 5.0 subject to Rule 16b-3 | 04/19/2024 |
7 | Disposition of 456413 shares by Schwab Andrew J. of Scpharmaceuticals at 4.09 subject to Rule 16b-3 | 04/26/2024 |
8 | scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024 | 05/07/2024 |
9 | scPharmaceuticals to Present at the H.C. Wainwright 2nd AnnualBioConnect Investor Conference | 05/13/2024 |
Check out Scpharmaceuticals Hype Analysis, Scpharmaceuticals Correlation and Scpharmaceuticals Performance. For more detail on how to invest in Scpharmaceuticals Stock please use our How to Invest in Scpharmaceuticals guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Scpharmaceuticals Stock analysis
When running Scpharmaceuticals' price analysis, check to measure Scpharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scpharmaceuticals is operating at the current time. Most of Scpharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Scpharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scpharmaceuticals' price. Additionally, you may evaluate how the addition of Scpharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |
Is Scpharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scpharmaceuticals. If investors know Scpharmaceuticals will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scpharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.42) | Revenue Per Share 0.353 | Return On Assets (0.32) | Return On Equity (1.00) |
The market value of Scpharmaceuticals is measured differently than its book value, which is the value of Scpharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Scpharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Scpharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scpharmaceuticals' market value can be influenced by many factors that don't directly affect Scpharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scpharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Scpharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scpharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.